Read more
4:27 PM · 2 April 2025

BREAKING: Novavax shares tumble as FDA misses deadline For Covid-19 vaccine approval

Novavax
Stocks
NVAX.US, Novavax Inc
-
-

The FDA has missed the deadline for making a key decision regarding a Novavax (NVAX.US) Covid-19 vaccine, days after the Food and Drug Administration’s vaccine chief was pushed out. Novavax’s application needed more data and was unlikely to be approved soon - was said by people familiar with a matter, citted by WSJ.

This information is seriously damaging the sentiment around the company and is undermining its current ability to maintain its business system. The shares are losing over 1.5%, although at one point the declines were as high as 4%.

 

Source: xStation 

29 October 2025, 9:00 PM

📉 Microsoft Q1 2026 Earnings: Strong Numbers Mask Investor Anxiety Over AI Spending

29 October 2025, 8:43 PM

🚀 Alphabet Soars on AI-Driven Results, Shares Rally 7% in After-Hours Trading

29 October 2025, 8:35 PM

Meta drops 8% despite strong revenue growth 🔎

29 October 2025, 4:31 PM

Upcoming Meta earnings: will the AI transformation be well received by the market? 🔎

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits